Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 801820 of 20,252 grants

Active NON-SBIR/STTR RPGS
Circadian regulation of astrocytic adenosine kinase in the irradiated and cancer brain
NATIONAL CANCER INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2024 – 2026

ABSTRACT Cranial radiotherapy (CRT) for CNS cancers leads to debilitating cognitive decline that is particularly concerning for pediatric and grade II/III brain cancer survivors. C...

$4.06M
USD
Active NON-SBIR/STTR RPGS
3' RNA modification enzymes regulate tumor angiogenesis in non-small lung cancer
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2026

Lung cancer is the leading cause of cancer-related mortality in the United States, and non-small cell lung cancer (NSCLC) comprises over 80 percent of all types of lung cancer. The...

$4.31M
USD
Completed OTHER RESEARCH-RELATED
Biological Methylation: Fundamental Mechanisms
NATIONAL CANCER INSTITUTE Federation of Amer Soc for Exper Biology United States 2024 – 2025

Abstract: The purpose of this R13 submission is to request funds to support a limited number of trainees, individuals identifying as underrepresented minorities (URMs), junior inve...

$140K
USD
Active NON-SBIR/STTR RPGS
3D wearable NIR spectral tomography for early prediction of breast cancer’s residual cancer burden after neoadjuvant chemotherapy
NATIONAL CANCER INSTITUTE Dartmouth College United States 2024 – 2029

Prediction of Residual Cancer Burden (RCB) early in treatment can enhance long-term survival outcomes for breast cancer patients undergoing neoadjuvant chemotherapy (NAC) and their...

$5.5M
USD
Active NON-SBIR/STTR RPGS
Molecular Functions of BRCA2 and RAD51 Paralogs in Homologous Recombination and Chromosome Maintenance
NATIONAL CANCER INSTITUTE University of California At Davis United States 2024 – 2029

Project Summary/Abstract The broad objective of this proposal is to understand the molecular mechanism of homologous recombination (HR) in humans, and to understand how the consequ...

$3.68M
USD
Active NON-SBIR/STTR RPGS
Role of disparities and aging biomarkers in accelerated cardiac aging among adolescent and young adult cancer survivors
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY AND ABSTRACT Cancer in adolescents and young adults (AYA) is defined as a diagnosis in individuals aged 15-39-years and is diagnosed in approximately 90,000 AYAs ea...

$6.92M
USD
Active TRAINING, INDIVIDUAL
Function of PD-1 Signaling on the Activity of B cells in the Tumor Microenvironment in Breast Cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2027

ABSTRACT The success of PD-1-targeted immune checkpoint inhibitor (ICI) therapy has revolutionized cancer treatment, becoming a new standard of care for various types of cancer. Ho...

$471.5K
USD
Active TRAINING, INDIVIDUAL
Investigating treatment strategies & clinical outcomes of histotripsy for complete ablation of osteosarcoma
NATIONAL CANCER INSTITUTE Virginia Polytechnic Inst and St Univ United States 2024 – 2026

Project Summary Osteosarcoma (OS) is a common and devastating primary bone tumor affecting both humans and canines. Histotripsy is an emerging non-thermal ablation modality that us...

$437.8K
USD
Completed SBIR-STTR RPGS
Automated rapid colonoscope insertion device to reduce physician injury and improve productivity
NATIONAL CANCER INSTITUTE Ergami Endoscopy, Inc United States 2024 – 2025

Colon cancer causes over 50,000 deaths each year in the US (12% of total cancer deaths). Colonoscopy (over 16 million procedures/year) is the most effective procedure for diagnosis...

$4M
USD
Active NON-SBIR/STTR RPGS
Ultra-Small Epigenetic-Regulating Nanocarrier for Enhanced Synthetic Lethal Therapy
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2024 – 2029

Project Summary: PARP inhibitors-based synthetic lethal therapy, such as BMN673 (Talazoparib), shows great efficacy for BRCA mutated (or homologous recombination repair (HRR)-defic...

$3.63M
USD
Active OTHER RESEARCH-RELATED
Improving Sexual and Reproductive Health Communication Between Adolescent and Young Adult Oncology Patients and Clinicians: A Patient-Centered Intervention
NATIONAL CANCER INSTITUTE Connecticut Children'S Medical Center United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT A cancer diagnosis directly threatens sexual and reproductive health (SRH), an essential component of healthy development in adolescents and young adults (...

$2.73M
USD
Active NON-SBIR/STTR RPGS
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Overview: The goal of this project is to assess the efficacy of a tailored phone-delivered positive psychological intervention (PATH) for improving anxiety...

$7.47M
USD
Active NON-SBIR/STTR RPGS
Defining signatures of epigenetic sensitization to lung cancer in a mouse model
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2026

PROJECT SUMMARY Epigenetic perturbations in cancer are widely recognized but poorly understood. A detailed understanding of how latent epigenetic information contributes to tumorig...

$2.35M
USD
Active NON-SBIR/STTR RPGS
Estimating Overdiagnosis After Implementation of Lung Cancer Screening in Community-Based Healthcare Systems
NATIONAL CANCER INSTITUTE Kaiser Foundation Research Institute United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Low-dose computed tomography (LDCT) has been accepted as an efficacious population-based approach for lung cancer screening (LCS) based on findings from th...

$1.58M
USD
Active OTHER RESEARCH-RELATED
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2029

Patients with life-threatening hematologic cancer experience insomnia and fatigue, distress, and pain symptoms that worsen insomnia during and following hospitalization for high-do...

$1.74M
USD
Active TRAINING, INDIVIDUAL
Hp1bp3 oversees chromatin remodeling to slow tumor growth in high grade glioma
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2026

PROJECT SUMMARY High grade glioma (HGG) is the most common malignant brain tumor in adults and is universally lethal. The standard of care for HGG has remained unchanged for over 3...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Developing KSHV-Infected Lymphatic Endothelial Cell-Based Models of Kaposi’s Sarcoma
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2026

PROJECT SUMMARY Kaposi’s Sarcoma-associated herpesvirus (KSHV) causes the AIDS-defining cancer Kaposi’s Sarcoma (KS). How KSHV infection causes KS is poorly understood, primarily d...

$4.11M
USD
Active NON-SBIR/STTR RPGS
Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT: Glioblastoma (GBM), the most prevalent malignant primary brain tumor, is an extremely aggressive form of diffuse glioma originating from astrocytic lineag...

$5.48M
USD
Active NON-SBIR/STTR RPGS
Melanocyte PDL1 control of UVB-induced IFN-I
NATIONAL CANCER INSTITUTE Dartmouth-Hitchcock Clinic United States 2024 – 2029

This new R01 proposal assembles a team with expertise in tumor immunology and immunotherapy, mouse cancer models, melanoma, IFN-I signals, tumor signaling, single cell spatial omic...

$6.36M
USD
Active NON-SBIR/STTR RPGS
Integrating Breast Cancer and Cardiovascular Disease Risk to Explore Decision-Making for Chemoprevention Among Racially/Ethnically Diverse Women at High Risk for Breast Cancer
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

Women with high-risk breast lesions, such as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS), have up to a 4- to 10-fold increased risk of invasive breast cancer (BC...

$6.84M
USD